The Dispensing Error Rate in an App-Based, Semaglutide-Supported Weight-Loss Service: A Retrospective Cohort Study
Digital weight-loss services (DWLSs) combining pharmacotherapy and health coaching have the potential to make a major contribution to the global struggle against obesity. However, the degree to which DWLSs compromise patient safety through the dispensation of Glucagon-like peptide-1 receptor agonist...
Saved in:
Main Authors: | Louis Talay (Author), Matt Vickers (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of semaglutide on osteoarthritis risk in patients with obesity: A retrospective cohort study
by: Onur Baser, et al.
Published: (2024) -
Effect of Adherence to Smartphone App Use on the Long-term Effectiveness of Weight Loss in Developing and OECD Countries: Retrospective Cohort Study
by: Myeunghee Han, et al.
Published: (2021) -
Long‐term weight loss maintenance with obesity pharmacotherapy: A retrospective cohort study
by: Beverly G. Tchang, et al.
Published: (2022) -
Semaglutide for the treatment of obesity
by: Rafał Oleszczuk, et al.
Published: (2022) -
Website Usage and Weight Loss in a Free Commercial Online Weight Loss Program: Retrospective Cohort Study
by: Hwang, Kevin O, et al.
Published: (2013)